News

2007 Press Releases

ImmuneRegen BioSciences Appoints Pranela Rameshwar to Advisory Board
December 18, 2007 7:00 AM ET

ImmuneRegen BioSciences and DelSite Biotechnologies to Collaborate on Development of Pandemic Flu Treatment 
December 3, 2007

ImmuneRegen BioSciences' Viprovex® Demonstrates Further Evidence for Effectiveness Against Influenza Virus, Including Avian Flu
November 12, 2007

ImmuneRegen BioSciences, Inc. Demonstrates Radilex® Increases Disease-Fighting White Blood Cells
August 27, 2007

ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
August 23, 2007

ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
August 16, 2007

ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
August 7, 2007

ImmuneRegen BioSciences, Inc. to Present Homspera™ at 2007 BARDA Industry Day
July 23, 2007

ImmuneRegen BioSciences, Inc. and Virion Systems, Inc. Continue Testing Viprovex® and Tamiflu(R) as Possible Influenza Co-Treatment
July 19, 2007

ImmuneRegen BioSciences Announces Development Partnership With Uluru Inc.
July 12, 2007

IR BioSciences Appoints Former VaxGen Chief Executive Lance K. Gordon Ph.D. to Its Board of Directors
May 15, 2007

IR BioSciences Announces Promising Data from Study of Its Compound Homspera Related information
May 7, 2007

ImmuneRegen BioSciences Appoints Dr. Frederick "Skip" M. Burkle, Jr. to Advisory Board
April 30, 2007

IR BioSciences Appoints Celgene Executive Dr. Robert Hariri to Its Board of Directors
April 24, 2007

ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
March 20, 2007

IR BioSciences, Inc. Responds to the Recently Cancelled Acute Radiation Syndrome (ARS) RFP by DHHS
March 14, 2007

IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
March 8, 2007

ImmuneRegen BioSciences Delivers Protocol for Upcoming Study With Roche's Stockpiled Antiviral Tamiflu
March 1, 2007

IR BioSciences Holdings, Inc. to Collaborate with Leading Clinical Services Company to Evaluate Radilex(TM) in Low-Level Radiation Exposure
February 26, 2007

Viprovex® Demonstrates Immune Response Potential in Treatment of Avian Influenza and Spanish Flu
February 8, 2007

ImmuneRegen BioSciences, Inc. Retains Battelle for Radiation and Infectious Disease Testing
January 18, 2007

ImmuneRegen Achieves Key Milestone in Testing of Potential Infectious Disease Treatment
January 16, 2007

Copyright © 2003-2008, ImmuneRegen Biosciences, Inc. All rights reserved.

News Archives

Press releases and news articles from

2007 >>

2006 >>

2005 >>

2004 >>